Skip to main content
. 2017 Apr 28;14(1):111–118. doi: 10.3892/ol.2017.6102

Figure 1.

Figure 1.

miR-4530 downregulates VASH1 expression in human breast carcinoma cells. (A) WT and Mut VASH1 mRNA of miR-4530 targeting sequences. Mutated sequences are indicated in bold type. (B) miR-4530 mimics inhibited WT but not Mut VASH1 reporter activity in HEK-293T cells. (C) miR-4530 downregulated the expression of endogenous VASH1 protein in human breast carcinoma cells compared with the empty plasmid control group. (D) miR-4530 significantly downregulated the expression of endogenous VASH1 mRNA in human breast carcinoma cells compared with the empty plasmid control group. WT, wild-type; Mut, mutant; 3′UTR, 3′-untranslated region; VASH1, vasohibin-1; miR, microRNA; ctrl, control. *P<0.05, **P<0.01.